Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 1, 2009, Pages 65-72

  Ozturk, Aysen ^a   Sarihan, Sureyya ^b   Ercan, Ilker ^b   Karadag, Mehmet ^b  

^a AOS Oncology Hospital   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

Long term survivor; Non small cell lung cancer; Pulmonary function; Quality of life; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE; PACLITAXEL;

ADULT; AGE; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COGNITION; COMORBIDITY; COMPARATIVE STUDY; CONSTIPATION; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; DYSPNEA; EDUCATION; EMOTIONALITY; FATIGUE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HEALTH INSURANCE; HUMAN; INSOMNIA; KARNOFSKY PERFORMANCE STATUS; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG SMALL CELL CANCER; MALE; MEDICAL RECORD REVIEW; PAIN; PASSIVE SMOKING; POSTOPERATIVE CARE; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SOCIAL STATUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; EVALUATION; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVOR; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; SURVIVAL RATE; SURVIVORS;

EID: 60549109128     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31817e6ec2     Document Type: Article

References (49)

1. SEER incidence and US death rates and 5-year relative survival rates. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Available at: http://seer.cancer.gov.
2. Curran WJ. Radiotherapy for locally advanced lung cancer: an overview. In: Pass IH, Mitchell JB, Johnson DH, et al. eds. Lung Cancer, Principles and Practice. 2nd ed. Philadelphia: Williams & Wilkins; 2000:823-828.
3. Emami B, Graham MV. Lung. In: Perez CA, Brady LW, eds. Principles and Practice of Radiation Oncology. 3rd ed. Philadelphia: JB Lippincott Company; 1998:1181-1120.
4. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85: 365-367.
5. Langendijk JA, Aaronson NK, de Jong JMA, et al. Prospective study on quality of life before and after radical radiotherapy in non-small cell lung cancer. J Clin Oncol. 2001;19:2123-2133.
6. Montazeri A, Gillis CR, McEwen J. Quality of life in patients with lung cancer. A review of literature from 1970 to 1995. Chest. 1998;113:467-481.
7. Cohen SR, Mount BM, Tomas JJ, et al. Existantial well-being is an important determinant of quality of life: Evidence from the McGill Quality of Life Questionnaire. Cancer. 1996;77:576-586.
8. Brady MJ, Peterman AH, Fitchett G, et al. A case for including spirituality in quality of life assessments in oncology. Psychooncology. 1999;8:417-428.
9. Sarna L, Evangelists L, Tashkin D, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004;125:439-445.
10. Ferguson MK, Skosey C, Hoffman PC, et al. Sex associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990;8: 1402-1407.
11. Zieren HU, Muller JM, Hamberger U, et al. Quality of life after surgical therapy of bronchogenic carcinoma. Eur J Cardiothorac Surg. 1996;10:233-237.
12. Pelkonen M, Notkola I-L, Tukiainen H, et al. Smoking cessation, decline in pulmoner function and total mortality: a 30 year follow-up study among the Finnish cohorts of the Seven Countries Study. Thorax. 2001;56:703-707.
13. Guzelant A, Goksel T, Ozkok S, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Eur J Cancer Care (Engl). 2004;13:135-144.
14. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis. 1991;144:1202-1218.
15. Nunnally JC, Berstein IH. Psychometric Theory. New York: McGraw-Hill. Inc.; 1994.
16. Chang JA, Curtis JR, Patrick DL, et al. Assessment of healty-related quality of life in patients with interstitial lung disease. Chest. 1999;116:1175-1182.
17. Martinez TY, Pereira CA, dos Santos ML, et al. Evaluation of the short form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2000;117:1627-1632.
18. Niezgoda HE, Pater JL. A validation study of the domains of the core EORTC guality of life questionnaire. Qual Life Res. 1993;2:319-325.
19. Ringdal GI, Ringdal K. Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res. 1993;2:129-140.
20. Osoba D, Aaronson N, Zee B, et al. Modification of the EORTC QLQ-C30 [version 2.0] based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the of the NCI of Canada Clinical Trials Group. Qual Life Res. 1997;6:103-108.
21. Kobayashi K, Takeda F, Teramukai S, et al. A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 [EORTC QLQ-C30] for Japanese with lung cancer. Eur J Cancer. 1998;34: 810-815.
22. Matsumoto T, Ohashi Y, Morita S, et al. The quality of life questionnaire for cancer patients treated with anticancer drugs [QOL-ACD]: validity and reliability in Japanese patients with advanced NSCLC. Qual Life Res. 2002; 11:483-493.
23. Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001;31:233-240.
24. Schag CA, Ganz PA, Wing DS, et al. Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res. 1994;3:127-141.
25. Ko CY, Maggard M, Livingston EH. Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide population-based assessment. J Surg Res. 2003;114:1-5.
26. Osoba D, Zee B, Pater J, et al. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire [QLQ-C30] in patients with breast, ovarian and lung cancer. Qual Life Res. 1994;3:353-364.
27. Buccheri GF, Ferrigno D, Tamburini M, et al. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer. 1995;12:45-58.
28. Nou E, Aberg T. Quality of survival in patients with surgically treated bronchial carcinoma. Thorax. 1980;35:255-263.
29. Mohan A, Mohan C, Bhutani M, et al. Quality of life in newly diagnosis patients with lung cancer in a developing country: is it important? Eur J Cancer Care (Engl). 2006;15:293-298.
30. Sarna L, Padilla G, Holmes C, et al. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol. 2002;20:2920-2929.
31. Movsas B, Scott C, Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group [RTOG] analysis. Int J Radiation Oncology Biol Phys. 2006;65:830-835.
32. Downe-Wamboldt B, Butler L, Coulter L. The relationship between meaning of illness, social support, coping strategies and quality of life for lung cancer patients and their family members. Cancer Nurs. 2006;29:111-119.
33. McDavid K, Tucker TC, Sloggett A, et al. Cancer survival in Kentucky and health insurance coverage. Arch Intern Med. 2003;163:2123-2124.
34. Greenberg ER, Chute CG, Stukel T, et al. Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Eng J med. 1988;318:612-617.
35. Ayanian JZ, Kohler BA, Abe T, et al. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Eng J Med. 1993;329:2039-2040.
36. Minet P, Bartsch P, Chevalier P, et al. Quality of life of inoperable non-small cell lung carcinoma. A randomized phase II clinical study comparing radio-therapy alone and combined radio-chemotherapy. Radiother Oncol. 1987;8: 217-30.
37. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients subjective experience of disease and psychosocial well being. Radiother Oncol. 1989;15:235-242.
38. Sugimura H, Yang P. Long-term survivorship in lung cancer: A review. Chest. 2006;129:1088-1097.
39. Doorenbos A, Given B, Given C, et al. Physical functioning: effect of behavioral intervention for symptoms among individuals with cancer. Nurs Res. 2006;55:161-71.
40. Tillmann M, Silcock J. Comparison of smokers' and ex-smokers' health-related quality of life. J Public Health Med. 1997;19:268-273.
41. Wilson D, Parsons J, Wakefield M. The health-related quality of life of never smokers, ex-smokers and light, moderate and heavy smokers. Prev Med. 1999;29:139-144.
42. Martinez JA, Mota GA, Vianna ES, et al. Impaired quality of life of healthy young smokers. Chest. 2004;125:425-428.
43. Strauss G, DeCamp M, Dibiccaro E, et al. Lung cancer diagnosis in being made with increasing frequency in former cigarette smokers [Meeting abstract]. Proc Am Soc Clin Oncol. 1995;14:362.
44. Gritz ER, Nisenbaum R, Elashoff RE, et al. Smoking behavior following diagnosis of patients with stage I non-small cell lung cancer. Cancer Causes Control. 1991;2:105-112.
45. Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following radical-intent therapy. Chest. 2003;123(1 suppl):272S-283S.
46. Tanaka K, Akechi T, Okuyama T, et al. Impact of dyspnea, pain and fatique on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002;23:417-423.
47. Ruffin RE, Wilson DH, Chittleborough CR, et al. Multiple respiratory symptoms predict quality of life in chronic lung disease: a population-based study of Australian adults. Qual Life Res. 2000;9:1031-1039.
48. Mahler DA, Faryniarz K, Tomlinson D, et al. Impact of dyspnea and physiologic function of general health status in patients with chronic obstructive pulmonary disease. Chest. 1992;102:395-401.
49. Mahler DA, Jones PW. Measurement of dyspnea and quality of life in advanced lung disease. Clin Chest Med. 1997;18:457-469.